Pros and Cons of Taro Pharmaceutical Industries Ltd in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Taro Pharmaceutical Industries Ltd vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Taro Pharmaceutical Industries Ltd | - | -0.505% | 1.026% | 69.828% | 4.787% | -35.935% | -58.618% |
| Opko Health Inc. | -1.990% | 3.324% | -2.352% | -8.830% | -14.933% | -64.295% | -42.276% |
| Repligen Corp. | -4.640% | 0.421% | -5.223% | 4.973% | -7.428% | -10.032% | - |
| Guangzhou Baiyunshan Pharmaceutical Holdings Co. Ltd. | 1.670% | 2.521% | 11.927% | -9.630% | 1.667% | 9.910% | -45.886% |
Comments
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) is now covered by analysts at StockNews.com. They set a "strong-buy" rating on the stock.
Show more
Ratings data for TARO provided by MarketBeat